Special
ASH 2021: Understanding the Crosstalk between Acute Leukemia and Down Syndrome for Designing Better Therapies
2021-12-16
Bioplus Interphex 2021: CDMOs- The Manufacturing Hub for the Next Generation of Therapeutics
2021-11-30
New Research on Neoantigens and Tumor-targeting T-cells Marks Paradigm Shift in Countering Solid Tumors
2021-11-19
How is China Driving Global Progress in Innovation and Access? – A Discussion with BeiGene CEO John Oyler
2021-11-16
Scientists Engineer RNA Switches for Targeted Delivery of Gene Therapy and RNA Therapeutics
2021-11-07
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23